VIMOVO

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Dostupno od:

ASTRA ZENECA ISRAEL LTD

ATC koda:

G02CC02

Farmaceutski oblik:

TABLETS MODIFIED RELEASE

Administracija rute:

PER OS

Proizveden od:

ASTRA ZENECA AB., SWEDEN

Terapijska grupa:

NAPROXEN

Terapijske indikacije:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Datum autorizacije:

2011-12-01